🇺🇸 FDA
Patent

US 10689413

Composition enriched in single isomer of NUC-1031 and preparation method and use thereof

granted A61KA61K31/7068A61P

Quick answer

US patent 10689413 (Composition enriched in single isomer of NUC-1031 and preparation method and use thereof) held by BrightGene Bio-Medical Technology Co., Ltd. expires Mon Jun 18 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BrightGene Bio-Medical Technology Co., Ltd.
Grant date
Tue Jun 23 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 18 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/7068, A61P, A61P35/00